Anthem Blue Cross Blue Shield of Indiana policy

MED.00135 Gene Therapy for Hemophilia

MED.00135 Gene Therapy for Hemophilia is a public Anthem Blue Cross Blue Shield of Indiana policy (policy MED.00135). It lists 6 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.

View the original policy ↗

Payer
Anthem Blue Cross Blue Shield of Indiana
Policy number
MED.00135
Line of business
Commercial
Source
www.anthem.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes.

CodeOther Anthem Blue Cross Blue Shield of Indiana policies
C9399Policies naming C9399
J1411Policies naming J1411
J1412Policies naming J1412
J1414Policies naming J1414
J3490Policies naming J3490
J3590Policies naming J3590

All Anthem Blue Cross Blue Shield of Indiana policies

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.